BioTime (Israel) Valuation Overview

BTX -- Israel Stock  

ILS 782.90  0.80  0.10%

BioTime shows prevailing Real Value of S634.149 per share. The current price of the firm is S782.9. At this time the firm appears to be over valued. Macroaxis approximates value of BioTime from analyzing the firm fundamentals such as Shares Outstanding of 126.87M, Return On Equity of (89.37)% and Operating Margin of (665.66)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Horizon     30 Days    Login   to change
BioTime is number one stock in beta category among related companies. It is number one stock in price to sales category among related companies fabricating about  84.17  of Price to Sales per Beta.

Current Market Valuation

BioTime Valuation Boundaries

Over Valued
October 20, 2018
782.90
Market Value
Downside
624.34
634.15
Real Value
Target Odds
  
861.19
Upside
BioTime is not too risky asset. Calculation of real value of BioTime is based on 1 month time horizon. Increasing BioTime time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com